This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations of Zhang Zhanxia in Nanotechnology
Introduction
Zhang Zhanxia is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of nanotechnology, particularly in the development of innovative substrates for controlled drug delivery and diagnostics. His work is characterized by a focus on the interaction between active agents and biomolecules.
Latest Patents
Zhang Zhanxia holds a patent for a "Recognition-release nanoporous substrate comprising active agents, methods of their preparation and uses." This invention relates to a porous substrate that contains at least one active agent trapped within its pores. The pores are capped by a nucleic acid sequence, which allows for the controlled release of the agent through a triggered reaction with specific analytes, or biomarkers. This technology has potential applications in the controlled administration of active agents and the diagnosis of medical conditions.
Career Highlights
Zhang Zhanxia is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this institution has allowed him to collaborate with leading researchers and contribute to advancements in nanotechnology and biomedical applications.
Collaborations
Zhang has worked alongside esteemed colleagues such as Itamar Willner and Dora Balogh. Their collaborative efforts have further enhanced the impact of their research in the scientific community.
Conclusion
Zhang Zhanxia's innovative work in the field of nanotechnology exemplifies the potential of scientific research to address complex medical challenges. His contributions continue to pave the way for advancements in drug delivery systems and diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
